Roche is putting $100 million behind an obesity target that looks promising but already has rivals. The shared headline doesn't name the target.
Recap by typeshit. Post by Facebook on Facebook.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
3:15
CBS News reports two deaths tied to an unregulated weight-loss drug sold outside approved channels. The full investigation has the details.
Melillo points to a side effect he feels gets too little attention: skin that becomes drier and looks less firm during treatment.
Loading…